Quest Diagnostics (DGX) Other Operating Expenses (2009 - 2026)

Quest Diagnostics has disclosed Other Operating Expenses across 18 years of filings, most recently posting -$2.0 million for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at -$2.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.0 million (up 1300.0% YoY), and the FY2025 annual result was $12.0 million, up 1300.0% from the prior year.
• Other Operating Expenses came in at -$2.0 million for Q1 2026 at Quest Diagnostics, down from $17.0 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $20.0 million in Q2 2025 to a low of -$35.0 million in Q4 2023.
• The 5-year median for Other Operating Expenses is -$2.0 million (2024), against an average of -$2.9 million.
• Peak annual rise in Other Operating Expenses reached 600.0% in 2025, while the deepest fall reached 2200.0% in 2025.
• Quest Diagnostics' Other Operating Expenses stood at -$21.0 million in 2022, then slumped by 66.67% to -$35.0 million in 2023, then jumped by 117.14% to $6.0 million in 2024, then surged by 183.33% to $17.0 million in 2025, then tumbled by 111.76% to -$2.0 million in 2026.
• The last three Other Operating Expenses figures came in at -$2.0 million (Q1 2026), $17.0 million (Q4 2025), and -$23.0 million (Q3 2025), per Business Quant data.